Evidence map›Paper›PMID 36382759›Full record

ReviewArchives of endocrinology and metabolism2022

Update on trabecular bone score.

Telma Palomo, Patricia Muszkat, Fernanda G Weiler, Patricia Dreyer, Cynthia M A Brandão, Barbara C Silva

Open access · diamondAbstract readReview
In one paragraph

Review in Archives of endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Trabecular bone score in adults with type 1 diabetes: a meta-analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024
    Pooled it
  2. Trial
  3. Trial
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Impact of Clinical Factors on Bone Microarchitecture in Patients with Turner Syndrome.Endocrine, metabolic & immune disorders drug targets · 2026
    Article
  12. Review
  13. Article
  14. Review
  15. Is trabecular bone score associated with appendicular lean mass?Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Telma PalomoServiço de Densitometria Óssea, Fleury Medicina e Saúde, São Paulo, SP, Brasil, telma.palomo@grupofleury.com.br.
Patricia MuszkatServiço de Densitometria Óssea, Fleury Medicina e Saúde, São Paulo, SP, Brasil.
Fernanda G WeilerServiço de Densitometria Óssea, Fleury Medicina e Saúde, São Paulo, SP, Brasil.
Patricia DreyerServiço de Densitometria Óssea, Fleury Medicina e Saúde, São Paulo, SP, Brasil.
Cynthia M A BrandãoServiço de Densitometria Óssea, Fleury Medicina e Saúde, São Paulo, SP, Brasil.
Barbara C SilvaUnidade de Endocrinologia, Santa Casa de Belo Horizonte, Belo Horizonte, MG, Brasil.
Fleury S.A. (Brazil) · BRCentro Universitário de Belo Horizonte · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trabecular bone score (TBS) is an indirect and noninvasive measure of bone quality. A low TBS indicates degraded bone microarchitecture, predicts osteoporotic fracture, and is partially independent of clinical risk factors and bone mineral density (BMD). There is substantial evidence supporting the use of TBS to assess vertebral, hip, and major osteoporotic fracture risk in postmenopausal women, as well as to assess hip and major osteoporotic fracture risk in men aged > 50 years. TBS complements BMD information and can be used to adjust the FRAX (Fracture Risk Assessment) score to improve risk stratification. While TBS should not be used to monitor antiresorptive therapy, it may be potentially useful for monitoring anabolic therapy. There is also a growing body of evidence indicating that TBS is particularly useful as an adjunct to BMD for fracture risk assessment in conditions associated with increased fracture risk, such as type-2 diabetes, chronic corticosteroid excess, and other conditions wherein BMD readings are often misleading. The interference of abdominal soft tissue thickness (STT) on TBS should also be considered when interpreting these findings because image noise can impact TBS evaluation. A new TBS software version based on an algorithm that accounts for STT rather than BMI seems to correct this technical limitation and is under development. In this paper, we review the current state of TBS, its technical aspects, and its evolving role in the assessment and management of several clinical conditions.

Indexed as

Cancellous BoneOsteoporotic FracturesAbsorptiometry, PhotonBone DensityFemaleHumansLumbar VertebraeMaleRisk Assessmentdual-energy X-ray absorptiometryfracture riskosteoporosissecondary osteoporosisTrabecular bone score

Identifiers

PMID36382759
PMCPMC10118821
OpenAlexW4309367674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.